These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31663662)

  • 1. Knowledge and attitudes of Parkinson's disease risk in the Gaucher population.
    Zaretsky L; Zeid N; Naik H; Alcalay RN; Balwani M
    J Genet Couns; 2020 Feb; 29(1):105-111. PubMed ID: 31663662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
    McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
    Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease in patients and obligate carriers of Gaucher disease.
    Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S
    Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?
    Di Rocco M; Di Fonzo A; Barbato A; Cappellini MD; Carubbi F; Giona F; Giuffrida G; Linari S; Pession A; Quarta A; Scarpa M; Spada M; Strisciuglio P; Andria G
    Orphanet J Rare Dis; 2020 Sep; 15(1):262. PubMed ID: 32967694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
    Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
    Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Parkinson's disease risk variant, p. W378R, in the Gaucher's disease GBA gene.
    Lubomski M; Hayes M; Kennerson M; Ellis M; Chu S; Blackie J; O'Sullivan JD; Nicholson G
    Mov Disord; 2018 Oct; 33(10):1662-1664. PubMed ID: 30216542
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease.
    Ribner A; Altarescu G; Zimran A; Elstein D
    Mov Disord; 2011 Jun; 26(7):1341-3. PubMed ID: 21469198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
    Shachar T; Lo Bianco C; Recchia A; Wiessner C; Raas-Rothschild A; Futerman AH
    Mov Disord; 2011 Aug; 26(9):1593-604. PubMed ID: 21618611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.
    Sato S; Li Y; Hattori N
    J Neural Transm (Vienna); 2017 Nov; 124(11):1395-1400. PubMed ID: 28894968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of Parkinson's disease in type 1 Gaucher disease.
    Bultron G; Kacena K; Pearson D; Boxer M; Yang R; Sathe S; Pastores G; Mistry PK
    J Inherit Metab Dis; 2010 Apr; 33(2):167-73. PubMed ID: 20177787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of Parkinson disease among patients with Gaucher disease.
    Elstein D; Alcalay R; Zimran A
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):249-59. PubMed ID: 25987177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Zimran A; Neudorfer O; Elstein D
    N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719452
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson's Disease.
    López de Frutos L; Almeida F; Murillo-Saich J; Conceição VA; Guma M; Queheberger O; Giraldo P; Miltenberger-Miltenyi G
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal thinning in Gaucher disease patients and carriers: results of a pilot study.
    McNeill A; Roberti G; Lascaratos G; Hughes D; Mehta A; Garway-Heath DF; Schapira AH
    Mol Genet Metab; 2013 Jun; 109(2):221-3. PubMed ID: 23639447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal recessive mutations in the development of Parkinson's disease.
    Lopez G; Sidransky E
    Biomark Med; 2010 Oct; 4(5):713-21. PubMed ID: 20945983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.
    Thaler A; Bregman N; Gurevich T; Shiner T; Dror Y; Zmira O; Gan-Or Z; Bar-Shira A; Gana-Weisz M; Orr-Urtreger A; Giladi N; Mirelman A
    Parkinsonism Relat Disord; 2018 Oct; 55():45-49. PubMed ID: 29784561
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Riboldi GM; Di Fonzo AB
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers.
    Mulhern M; Bier L; Alcalay RN; Balwani M
    J Genet Couns; 2018 Jun; 27(3):675-680. PubMed ID: 28963610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals.
    Gatto EM; Etcheverry JL; Sanguinetti A; Cesarini M; Fernandez Escobar N; Drelichman G
    Eur Neurol; 2016; 76(1-2):19-21. PubMed ID: 27344356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The motor and cognitive features of Parkinson's disease in patients with concurrent Gaucher disease over 2 years: a case series.
    Collins LM; Williams-Gray CH; Morris E; Deegan P; Cox TM; Barker RA
    J Neurol; 2018 Aug; 265(8):1789-1794. PubMed ID: 29845374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.